{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-003111","form_type":"8-K","ticker":"BCPC","cik":"0000009326","company_name":"BALCHEM CORP","filed_at":"2022-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.441364+00:00","generated_at":"2026-06-27T06:50:10.943938+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Balchem Q4 record sales $213M (+17.9% YoY); adj. EPS $0.85; dividend up 10.3%","bullets":["Q4 net sales $213.1M (+17.9% YoY); GAAP EPS $0.76, adjusted EPS $0.85 (up from $0.83).","Full year net sales $799M (+13.6%); GAAP EPS $2.94 record, adjusted EPS $3.57.","Record Q4 adjusted EBITDA $45.6M (+4.7%); FY adjusted EBITDA $189.8M (+8.9%).","Increased quarterly dividend to $0.64/share (+10.3%), 12th consecutive year of double-digit growth.","Q4 ops cash $44.5M; free cash flow $124.4M FY; net debt reduced to $5.3M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-003111","json":"https://secwatch.observer/filing/0001628280-22-003111.json","markdown":"https://secwatch.observer/filing/0001628280-22-003111.md","text":"https://secwatch.observer/filing/0001628280-22-003111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/9326/000162828022003111/0001628280-22-003111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/9326/000162828022003111/bcpc-20220218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T06:50:10.943938+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}